Will the DOJ’s investigation into a16z spook other VCs?
THE SO WHAT
A DOJ look at VC board seats is a warning that governance and control rights are moving from private negotiation into regulatory scrutiny. Founders and funds should expect slower deals, more paperwork, and tighter conflict-of-interest standards around board participation.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureJuicy Yields Draw Junk Bond Buyers to Investment-Grade AI Debt
Investment-grade data center builders tapping junk-bond buyers for billions says AI infra is now a fixed-income asset class with its own risk/return profile. If you’re on the build side, capital is there but expects yield — structure projects so they can stand on their own cash flows, not just equity stories.
Startups & VentureHow AI accounting startup Rillet raised $100M and became a unicorn in 48 hours
A vertical AI accounting startup hitting a $100M round and unicorn status in 48 hours tells you capital is still chasing deep workflow penetration over generic copilots. If you’re in a regulated, repeatable back-office domain, assume specialized AI entrants will get funded to go after your margin structure.
Sources: Devoted Health, which uses AI to help coordinate medical care for those enrolled in Medicare Advantage, is raising new funding at a $25B valuation
A Medicare Advantage-focused care coordination startup reaching a rumored $25B valuation shows how much premium investors put on AI that touches reimbursement and risk scoring. Health operators should expect payer-facing AI workflows—triage, coordination, documentation—to be where capital and regulatory scrutiny concentrate next.
Startups & VentureLearn what VCs actually want, from a founder who’s raised $1B
The leverage point in fundraising is moving from pitch quality to metric literacy — messy data and late-stage runway panic are now explicit valuation penalties, not just red flags. Founders should treat finance ops and cohort clarity as go-to-market infrastructure, not back-office hygiene.